Yasuyuki Kojima Selected Research

Yasuyuki Kojima Research Topics

Disease

20	Breast Neoplasms (Breast Cancer) 07/2022 - 06/2008
20	Neoplasms (Cancer) 05/2021 - 10/2003
5	Triple Negative Breast Neoplasms 09/2021 - 01/2016
4	Neoplasm Metastasis (Metastasis) 07/2020 - 02/2015
3	Carcinoma (Carcinomatosis) 07/2022 - 01/2008
3	Hypertension (High Blood Pressure) 12/2011 - 08/2008
2	Lymphatic Metastasis 01/2022 - 01/2020
2	Meningeal Carcinomatosis 07/2020 - 07/2020
2	Renal Cell Carcinoma (Grawitz Tumor) 11/2011 - 10/2003
2	Adenocarcinoma 01/2010 - 10/2005
1	Hypersensitivity (Allergy) 09/2021
1	Peripheral Nervous System Diseases (PNS Diseases) 09/2021
1	Pathologic Complete Response 05/2021
1	Anorexia 01/2021
1	Nausea 01/2021
1	Fatigue 01/2021
1	Vomiting 01/2021
1	Sleepiness 01/2021
1	Brain Neoplasms (Brain Tumor) 07/2020
1	Cardiotoxicity 12/2019
1	Fibroadenoma 07/2015
1	Leiomyoma (Uterine Fibroids) 07/2015
1	Proteinuria 12/2011
1	Albuminuria 12/2011
1	Stomach Neoplasms (Stomach Cancer) 01/2010
1	Anuria 01/2010
1	Adenoma (Adenomas) 01/2010
1	Hyperaldosteronism (Conn Syndrome) 01/2010
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2010

Drug/Important Bio-Agent (IBA)

7	human ERBB2 proteinIBA 09/2021 - 09/2016
6	taxaneIBA 09/2021 - 09/2016
5	Trastuzumab (Herceptin)FDA Link 05/2020 - 09/2016
4	AnthracyclinesIBA 01/2021 - 09/2016
3	Phenobarbital (Luminal)FDA Link 09/2021 - 01/2016
3	eribulin FDA Link 05/2020 - 10/2019
3	Estrogen ReceptorsIBA 01/2020 - 01/2016
3	Biomarkers (Surrogate Marker)IBA 12/2019 - 08/2008
2	Ethanol (Ethyl Alcohol)IBA 09/2021 - 10/2003
2	Albumin-Bound Paclitaxel FDA Link 09/2021 - 10/2018
2	ErbB Receptors (EGF Receptor)IBA 05/2021 - 12/2018
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 10/2018
2	Hormones (Hormone)IBA 11/2020 - 09/2009
2	pertuzumabIBA 05/2020 - 01/2020
2	Fluorouracil (Carac)FDA LinkGeneric 01/2019 - 10/2018
2	Cadherins (E-Cadherin)IBA 09/2014 - 01/2010
2	PKC-3 proteinIBA 09/2014 - 09/2009
2	PotassiumIBA 12/2011 - 01/2010
2	CreatinineIBA 12/2011 - 11/2003
2	Proteins (Proteins, Gene)FDA Link 01/2010 - 06/2008
2	protein kinase C lambdaIBA 01/2010 - 06/2008
1	cremophorIBA 09/2021
1	AntiemeticsIBA 01/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021
1	Drug CombinationsIBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	Olanzapine (Zyprexa)FDA Link 01/2021
1	SteroidsIBA 01/2021
1	Aprepitant (Emend)FDA Link 01/2021
1	Palonosetron (Aloxi)FDA Link 01/2021
1	Epidermal Growth Factor (EGF)IBA 05/2020
1	Genetic Markers (Genetic Marker)IBA 12/2019
1	Lapatinib (GW572016)FDA Link 01/2019
1	Capecitabine (Xeloda)FDA Link 01/2019
1	Ado-Trastuzumab EmtansineIBA 01/2019
1	Selective Estrogen Receptor Modulators (SERM)IBA 12/2018
1	AlbuminsIBA 10/2018
1	Epirubicin (Ellence)FDA LinkGeneric 10/2018
1	130-nm albumin-bound paclitaxelIBA 10/2018
1	Docetaxel (Taxotere)FDA Link 09/2016
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2016
1	olaparibIBA 08/2015
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 08/2015
1	Histone Deacetylase InhibitorsIBA 08/2015
1	Mediator ComplexIBA 07/2015
1	Gemcitabine FDA Link 02/2015
1	Cisplatin (Platino)FDA LinkGeneric 02/2015
1	CateninsIBA 09/2014
1	Collagen Type IV (Type IV Collagen)IBA 09/2014
1	Angiotensin IIIBA 12/2011
1	ReninIBA 12/2011
1	Hemoglobins (Hemoglobin)IBA 12/2011
1	candesartanIBA 12/2011
1	AldosteroneIBA 01/2010
1	Indicators and Reagents (Reagents)IBA 01/2010

Therapy/Procedure

7	Neoadjuvant Therapy 09/2021 - 01/2016
4	Therapeutics 07/2022 - 02/2015
3	Radiotherapy 01/2022 - 07/2020
3	Drug Therapy (Chemotherapy) 01/2021 - 02/2015
2	Adjuvant Chemotherapy 01/2020 - 02/2015
2	Kidney Transplantation 02/2015 - 08/2008
2	Transplantation 08/2008 - 10/2003
1	Aftercare (After-Treatment) 03/2022
1	Mastectomy (Mammectomy) 11/2016
1	Skin Transplantation (Skin Grafting) 07/2016
1	Lymph Node Excision (Lymph Node Dissection) 01/2016
1	TP protocol 02/2015
1	Combination Drug Therapy (Combination Chemotherapy) 02/2015
1	Nephrectomy 11/2011
1	Gastrectomy 01/2010
1	Adrenalectomy 01/2010